Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration.

Cloutier N, Allaeys I, Marcoux G, Machlus KR, Mailhot B, Zufferey A, Levesque T, Becker Y, Tessandier N, Melki I, Zhi H, Poirier G, Rondina MT, Italiano JE, Flamand L, McKenzie SE, Cote F, Nieswandt B, Khan WI, Flick MJ, Newman PJ, Lacroix S, Fortin PR, Boilard E.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1550-E1559. doi: 10.1073/pnas.1720553115. Epub 2018 Jan 31.

PMID:
29386381
2.

Optimized plasma preparation is essential to monitor platelet-stored molecules in humans.

Mussbacher M, Schrottmaier WC, Salzmann M, Brostjan C, Schmid JA, Starlinger P, Assinger A.

PLoS One. 2017 Dec 8;12(12):e0188921. doi: 10.1371/journal.pone.0188921. eCollection 2017.

3.

The impact of hyperglycemia and hyperlipidemia on plasma P-selectin and platelet markers after ischemic stroke.

Pawelczyk M, Kaczorowska B, Baj Z.

Arch Med Sci. 2017 Aug;13(5):1049-1056. doi: 10.5114/aoms.2017.65816. Epub 2017 Feb 1.

4.

Circulating soluble P-selectin must dimerize to promote inflammation and coagulation in mice.

Panicker SR, Mehta-D'souza P, Zhang N, Klopocki AG, Shao B, McEver RP.

Blood. 2017 Jul 13;130(2):181-191. doi: 10.1182/blood-2017-02-770479. Epub 2017 May 17.

PMID:
28515093
5.

Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy.

Arvanitidis E, Bizzarro S, Alvarez Rodriguez E, Loos BG, Nicu EA.

Thromb J. 2017 Feb 6;15:5. doi: 10.1186/s12959-016-0125-x. eCollection 2017.

6.

Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk.

Papadavid E, Diamanti K, Spathis A, Varoudi M, Andreadou I, Gravanis K, Theodoropoulos K, Karakitsos P, Lekakis J, Rigopoulos D, Ikonomidis I.

World J Cardiol. 2016 Nov 26;8(11):667-675.

7.

Haemodiafiltration elicits less platelet activation compared to haemodialysis.

Becs G, Hudák R, Fejes Z, Debreceni IB, Bhattoa HP, Balla J, Kappelmayer J.

BMC Nephrol. 2016 Oct 13;17(1):147.

8.

Flow Cytometric Investigation of Classical and Alternative Platelet Activation Markers.

Nagy B Jr, Debreceni IB, Kappelmayer J.

EJIFCC. 2013 Jan 16;23(4):124-34. eCollection 2013 Jan.

9.

The Dynamics of Platelet Activation during the Progression of Streptococcal Sepsis.

Hurley SM, Lutay N, Holmqvist B, Shannon O.

PLoS One. 2016 Sep 22;11(9):e0163531. doi: 10.1371/journal.pone.0163531. eCollection 2016.

10.

Coagulation Biomarkers in Healthy Chinese-Origin Rhesus Macaques (Macaca mulatta).

Frydman GH, Bendapudi PK, Marini RP, Vanderburg CR, Tompkins RG, Fox JG.

J Am Assoc Lab Anim Sci. 2016;55(3):252-9.

11.

A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial.

Ypma PF, van der Meer PF, Heddle NM, van Hilten JA, Stijnen T, Middelburg RA, Hervig T, van der Bom JG, Brand A, Kerkhoffs JL; PREPAReS Study Group.

BMJ Open. 2016 Jan 27;6(1):e010156. doi: 10.1136/bmjopen-2015-010156.

12.

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model.

Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, Ecob R, Judge HM, Khan H, West LE, Dockrell DH, Sabroe I, Storey RF.

Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2562-70. doi: 10.1161/ATVBAHA.115.306528. Epub 2015 Oct 29.

13.

Selectins: initiators of leucocyte adhesion and signalling at the vascular wall.

McEver RP.

Cardiovasc Res. 2015 Aug 1;107(3):331-9. doi: 10.1093/cvr/cvv154. Epub 2015 May 20. Review.

14.

The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke.

Pawelczyk M, Chmielewski H, Kaczorowska B, Przybyła M, Baj Z.

Arch Med Sci. 2015 Mar 16;11(1):115-21. doi: 10.5114/aoms.2015.49216. Epub 2015 Mar 14.

15.

Platelet transfusion - the new immunology of an old therapy.

Stolla M, Refaai MA, Heal JM, Spinelli SL, Garraud O, Phipps RP, Blumberg N.

Front Immunol. 2015 Feb 2;6:28. doi: 10.3389/fimmu.2015.00028. eCollection 2015. Review.

16.

Platelets and their chemokines in atherosclerosis-clinical applications.

von Hundelshausen P, Schmitt MM.

Front Physiol. 2014 Aug 8;5:294. doi: 10.3389/fphys.2014.00294. eCollection 2014. Review.

17.

Endothelial C-type natriuretic peptide maintains vascular homeostasis.

Moyes AJ, Khambata RS, Villar I, Bubb KJ, Baliga RS, Lumsden NG, Xiao F, Gane PJ, Rebstock AS, Worthington RJ, Simone MI, Mota F, Rivilla F, Vallejo S, Peiró C, Sánchez Ferrer CF, Djordjevic S, Caulfield MJ, MacAllister RJ, Selwood DL, Ahluwalia A, Hobbs AJ.

J Clin Invest. 2014 Sep;124(9):4039-51. doi: 10.1172/JCI74281. Epub 2014 Aug 8.

18.

Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas.

Thaler J, Ay C, Kaider A, Reitter EM, Haselböck J, Mannhalter C, Zielinski C, Marosi C, Pabinger I.

Neuro Oncol. 2014 Dec;16(12):1645-51. doi: 10.1093/neuonc/nou106. Epub 2014 Jul 1.

19.

Blood-banking techniques for plateletpheresis in swine.

Sondeen JL, Prince MD, Polykratis IA, Hernandez O, Torres-Mendoza J, De Guzman R, Aden JK, Dubick MA.

J Am Assoc Lab Anim Sci. 2014 May;53(3):307-16.

20.

Long-term outcomes of rheohaemapheresis in the treatment of dry form of age-related macular degeneration.

Studnička J, Rencová E, Bláha M, Rozsíval P, Lánská M, Bláha V, Němčanský J, Langrová H.

J Ophthalmol. 2013;2013:135798. doi: 10.1155/2013/135798. Epub 2013 Dec 18.

Supplemental Content

Support Center